Caplin Point Laboratories Ltd.
Snapshot View

687.50 -0.75 ▼-0.1%

27 January 2023, 04:01:00 PM
Volume: 5,036

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.caplinpoint.net
Market Cap 5,203.17 Cr.
Enterprise Value(EV) 4,706.36 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 43.57 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 15.78 Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 222.11 Trailing Twelve Months Ending 2022-09
Price to Book Value 3.10 Calculated using Price: 687.50
Dividend Yield 0.58 Period Ending 2022-03
No. of Shares Subscribed 7.59 Cr. 75,897,746 Shares
FaceValue 2
Company Profile
Caplin Point is the mid-sized company in India's pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.11%
1 Week
-1.24%
1 Month
-3.77%
3 Month
-8.10%
6 Month
-9.14%
1 Year
-15.13%
2 Year
+47.42%
5 Year
+6.19%
10 Year
+3999.58%
9 years 2014-06 2015-06 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 53.24 55.78 43.13 54.97 49.43 37.14 29.58 25.65 24.71
Return on Capital Employed (%) 68.99 71.11 55.41 69.03 64.08 45.59 33.35 28.82 28.77
Return on Assets (%) 16.48 20.12 18.46 30.54 33.68 28.41 23.02 20.20 19.94

Balance Sheet View Details >>

Particulars 10 years 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 62 93 128 225 364 633 948 1,186 1,484 1,686
Non Curr. Liab. 10 10 14 20 28 23 25 17 13 5
Curr. Liab. 108 125 125 113 109 86 144 143 208 294
Minority Int. 0 0 0 0 0 0 9 18 26 28
Equity & Liab. 180 229 267 358 500 743 1,126 1,364 1,730 2,012
Non Curr. Assets 131 147 149 179 196 249 303 349 432 468
Curr. Assets 49 82 119 179 304 494 823 1,015 1,298 1,544
Misc. Exp. not W/O
Total Assets 180 229 267 358 500 743 1,126 1,364 1,730 2,012

Profit Loss View Details >>

Particulars 10 years 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 173 252 239 402 540 649 863 1,061 1,269 1,371
Other Income 4 3 4 10 13 19 41 28 39 51
Total Income 177 255 242 412 553 668 905 1,089 1,308 1,422
Total Expenditure -137 -192 -175 -277 -345 -417 -603 -737 -875 -962
PBIDT 40 63 68 135 208 251 301 352 433 460
Interest -1 -1 0 -1 -1 -1 0 -2 -1 0
Depreciation -4 -8 -7 -13 -19 -23 -32 -37 -47 -46
Taxation -10 -12 -14 -25 -44 -50 -54 -62 -77 -76
Exceptional Items
PAT 26 41 46 96 145 177 215 251 308 338
Minority Interest 0 0 0 0 0 -9 -9 -8
Share Associate 0
Other Related Items
Consolidated Net Profit 26 41 46 96 145 177 215 242 300 331
Adjusted EPS 3 5 6 13 19 23 28 32 40 44

Cash Flow View Details >>

Particulars 10 years 2013-06 Rs. Cr. 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 32 60 50 42 68 66 83 45 269 337
Cash Fr. Inv. -45 -44 -23 -6 -36 -69 -100 -55 -29 -271
Cash Fr. Finan. -1 -6 -9 -14 -7 -12 90 80 -24 -41
Net Change -15 10 19 23 25 -14 73 70 215 25
Cash & Cash Eqvt 17 27 45 68 91 77 151 221 436 461

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 69.03 69.03 69.03 69.03 68.91 68.89 68.88 68.88 68.80
Public 30.97 30.97 30.97 30.97 31.09 31.11 31.12 31.12 31.20
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 12 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Share certificates has been reported as lost by the shareholders of the Company.
Thu, 05 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform that below mentioned share certificates has been reported as lost by the shareholders of the Company.
Wed, 04 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018

Technical Scans View Details >>

Fri, 27 Jan 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Caplin Point Laboratories Ltd.

What is Caplin Point Lab share price?

Can I buy Caplin Point Lab shares now?

What is the Dividend Yield of Caplin Point Lab?

What is the Market Cap of Caplin Point Lab?

What are the key metrics to analyse Caplin Point Lab?

What is the 52 Week High and Low of Caplin Point Lab?

What is the trend of Caplin Point Lab share price?